In recent years, with the diversification of drug modalities, including regenerative medicine products, non-clinical trials and research (translational research) have become increasingly complex in order to apply therapeutic tools (seeds) discovered in basic research to clinical practice. In response, various regulations have been tightened, and some businesses and/or organizations may find it difficult to comply with them.
We provide consulting and advisory services for non-clinical studies in order to ensure early and efficient application of seeds into clinical practice.
By collaborating with other companies (CROs, etc.) with which we have built relationships over many years in our nonclinical research business, we are able to respond to difficult requests.
Our advisory services are not limited to products for medical purposes, but also for general-purpose chemicals and industrial products.